Physician profile

Bose Cheeran

Interventional Cardiology · Lafayette, LA

NPI 1649448598

$9,639.29

in general payments reported to CMS, 2019-2025

41 companies · $840 in 2025

The $840 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,308.07
Travel and Lodging$1,559.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $2,427.43 2023 Indigo System
Boston Scientific Corporation $1,228.69 2019-2024 Accolade Sr
Pfizer INC. $837.01 2019-2025
Abiomed $641.04 2021-2025 Impella
Janssen Pharmaceuticals, INC $609.00 2019-2024 Xarelto
Novartis Pharmaceuticals Corporation $534.67 2019-2025
Imperative Care, INC $362.99 2024-2025 Symphony Catheter, Prodigy Catheter
Shockwave Medical, INC $270.69 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Abbott Laboratories $257.47 2019-2024 Esprit, Cardiomems, Diamondback Peripheral
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $256.49 2019-2025 Lifevest
Amgen INC. $213.16 2019-2025 Repatha, Repatha
Bard Peripheral Vascular, INC. $204.49 2019-2021
Medtronic Vascular, INC. $153.62 2019-2020
Surmodics, INC. $145.36 2022
Inari Medical, INC. $137.74 2019
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Organogenesis INC. $124.58 2022
Merck Sharp & Dohme LLC $123.71 2021-2024 Verquvo
Medtronic, INC. $122.75 2021-2025 In.Pact Admiral, Linq II, Plasmablade(Tm)
Scpharmaceuticals INC. $112.15 2024-2025
Alnylam Pharmaceuticals INC. $104.77 2023-2024 Onpattro
Amarin Pharma, INC. $70.84 2019-2020
Kestra Medical Technology Services, INC. $69.40 2025 Assure Wcd
Boehringer Ingelheim Pharmaceuticals, INC. $65.40 2019-2021
Philips North America LLC $60.32 2019-2021
Cardiovascular Systems INC. $57.30 2021-2022
Biotronik INC. $55.64 2023-2024 Acticor 7 Vr-T Dx
Astrazeneca Pharmaceuticals LP $46.64 2019-2020
Edwards Lifesciences Corporation $45.35 2023 Sapien 3 Ultra Resilia
Regeneron Healthcare Solutions, INC. $39.63 2019
E.R. Squibb & Sons, L.L.C. $33.90 2024 Camzyos, Eliquis
Novo Nordisk INC $33.15 2025 Wegovy
United Therapeutics Corporation $31.49 2019-2020
Arbor Pharmaceuticals, INC. $27.98 2019-2020
Sanofi-Aventis U.S. LLC $23.86 2019
Lundbeck LLC $19.92 2019
Kowa Pharmaceuticals America, INC. $18.65 2019
Chiesi USA, INC. $15.97 2019
Gilead Sciences, INC. $15.33 2019
Bayer Healthcare Pharmaceuticals INC. $14.56 2022
Terumo Medical Corporation $13.77 2022
Esperion Therapeutics, INC. $12.38 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bose Cheeran

$9,639.29

in general payments reported 2019-2025

Years
2019-2025
Top company
Penumbra, INC.
Context
The $840 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/165155/bose-cheeran

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.